Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer.

12 Sep 2016Zhang M, Viennois E, Prasad M, Zhang Y, Wang L, Zhang Z, Han MK, Xiao B, Xu C, Srinivasan S, Merlin D

Nanoparticles derived from edible ginger, represent a novel, natural delivery mechanism for improving IBD prevention and treatment with an added benefit of overcoming limitations such as potential toxicity and limited production scale that are common with synthetic nanoparticles.

Animal Research
3 effects

Reported Outcomes

DeterminantsOutcomeDetails

Ginger Herb risk & protective factor
Minor Protective Factor Ginger
Herb

Colorectal Cancer Digestive outcome
Minor decreased risk of Colorectal Cancer
Digestive system

Low evidence
-3.0%

Ginger Herb risk & protective factor
Minor Protective Factor Ginger
Herb

Inflammatory bowel disease (IBD) Digestive outcome
Minor decreased risk of Inflammatory bowel di...
Digestive system

Low evidence
-3.0%

Ginger Herb risk & protective factor
Minor Protective Factor Ginger
Herb

Inflammation Lymphatic outcome
Minor decreased risk of Inflammation
Lymphatic system

Low evidence
-3.0%